Last reviewed · How we verify
NCT04484298: dyvic2
Dynamic Variation of Impedance Cardiography(DYVIC) as a Diagnostic Tool of Acute Heart Failure (AHF)
NA trial testing Reference position patient is put in a 30 degree supine position during 5 minutes in Heart Failure in 100 participants. Completed in 1 March 2020.
29 February 2020
Quick facts
| Lead sponsor | University of Monastir |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | diagnostic |
| Enrollment | 100 |
| Start date | 2 January 2019 |
| Primary completion | 29 February 2020 |
| Estimated completion | 1 March 2020 |
| Sites | 1 location across Tunisia |
Drugs / interventions tested
- Reference position patient is put in a 30 degree supine position during 5 minutes
- nitroglucerin
Conditions studied
- Heart Failure — all drugs for Heart Failure →
Sponsor
University of Monastir
Who can join
18 and older, any sex, with Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the study aimed to evaluate the diagnostic performance of cardiac output (CO) change after the use of trinitrine in the diagnosis of heart failure patients with acute dyspnea.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Value of nitroglycerin test in the diagnosis of heart failure in emergency department patients with undifferentiated dyspnea.
Sekma A, Bel Haj Ali K, Jeddi C, Ben Brahim N, et al · · 2021 · cited 2× · PMID 34076282 · DOI 10.1002/clc.23615
Verify or expand the search:
- PubMed search for NCT04484298
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other University of Monastir trials
Trials by the same sponsor.
- NCT07345156 — Congestion and LActate at diScHarge in Acute Heart Failure · not yet recruiting
- NCT07181642 — Diaphragmatic Breathing for Sleep Bruxism in Adults: A Randomized Controlled Trial · NA · completed
- NCT06980727 — Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED · Phase 3 · not yet recruiting
- NCT06900972 — Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial · Phase 3 · enrolling by invitation
- NCT06723002 — Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome · Phase 2, PHASE3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04484298 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Monastir
- Last refreshed: 29 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04484298.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing